2017;18(4):446-53. 36. Chung HC, Kok VC, Cheng R, Hsu Y, Orlando M, Fuchs C, et al. Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer. Asia Pac J Clin Oncol. 2018;14(3):204-9. 37. Ott PA, Hodi FS, Kaufman HL, Wigginton JM, Wolchok JD. Combination immunotherapy: a road map. J Immunother Cancer. 2017;5:16. 38.